Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Molecular Signatures of CB-6644 Inhibition of the RUVBL1/2 Complex in Multiple Myeloma

International Journal of Molecular Sciences(2024)10.3390/ijms25169022Source: DataRank Database

Molecular Signatures of CB-6644 Inhibition of the RUVBL1/2 Complex in Multiple Myeloma is a research paper published in International Journal of Molecular Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.82)OA: goldTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Sebastian A. Dziadowicz ORCID,R Mangano ORCID,Lei Wang ORCID,Joseph C McBee,Steven M. Frisch ORCID

Live enrichment

PubMed:39201707 PMC:PMC11354775 OpenAlex:https://openalex.org/W4401973409

NIH NIGMS

Grant: P20 GM103434

NIH NIGMS

Grant: U54 GM104942

NIH NIGMS

Grant: P20 GM121322

NIH NIGMS

Grant: 2125872

FWCI

1.82

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/25/16/9022/pdf?version=1724136857

publisherhttps://www.mdpi.com/1422-0067/25/16/9022/pdf?version=1724136857

publisherhttps://www.mdpi.com/1422-0067/25/16/9022/pdf

journalhttps://doi.org/10.3390/ijms25169022

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39201707

Fields of Study

Multiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsUbiquitin and proteasome pathways

MeSH Terms

ATPases Associated with Diverse Cellular ActivitiesAntineoplastic AgentsCarrier ProteinsDNA HelicasesHumansMultiple MyelomaTranscription FactorsGene Expression Regulation, NeoplasticChromatin Assembly and DisassemblyEpigenesis, GeneticCell Line, TumorCell Proliferation

Keywords

ChromatinChromatin remodelingEpigeneticsBiologyCancer researchTranscriptional regulationTranscription factorDownregulation and upregulationMolecular biologyCell biologyGeneGeneticsMultiple myelomaMolecular SignaturesRuvbl1/2Cb-6644

Sustainable Development Goals

SDG 0: Good health and well-being

Molecular Signatures of CB-6644 Inhibition of the RUVBL1/2 Complex in Multiple Myeloma

FAIR Checklist

Authors (9)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)